Avg Qtr Burn
Short % of Float
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
|Drug & Indication||Stage & Event||Catalyst Date|
Etavopivat (FT-4202) (PKR activator) Details
Sickle cell disease
FT-7051 (CBP/P300 inhibitor) Details
Castration-resistant prostate cancer